These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 10376261

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The additive effect of latanoprost to maximum-tolerated medications with low-dose, high-dose, or no pilocarpine therapy.
    Shin DH, McCracken MS, Bendel RE, Pearlman R, Juzych MS, Hughes BA, Schulz LL, Kim C, Baek NH.
    Ophthalmology; 1999 Feb; 106(2):386-90. PubMed ID: 9951495
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effect of 0.005% latanoprost once daily on intraocular pressure in glaucomatous patients not adequately controlled by beta-blockers twice daily: a 3-year follow-up. Experience and incidence of side effects in a prospective study on 76 patients.
    Costagliola C, Del Prete A, Verolino M, Antinozzi P, Fusco R, Parmeggiani F, Mastropasqua L.
    Graefes Arch Clin Exp Ophthalmol; 2002 May; 240(5):379-86. PubMed ID: 12073061
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effects of latanoprost 50 micrograms/ml on Chinese patients with primary open-angle glaucoma and ocular hypertension.
    Liu CJ, Chou JC, Hsu WM, Liu JH.
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 Oct; 62(10):703-9. PubMed ID: 10533300
    [Abstract] [Full Text] [Related]

  • 11. Latanoprost 0.005% versus bimatoprost 0.03% in primary open-angle glaucoma patients.
    Konstas AG, Katsimbris JM, Lallos N, Boukaras GP, Jenkins JN, Stewart WC.
    Ophthalmology; 2005 Feb; 112(2):262-6. PubMed ID: 15691561
    [Abstract] [Full Text] [Related]

  • 12. Twenty-four-hour diurnal curve comparison of commercially available latanoprost 0.005% versus the timolol and dorzolamide fixed combination.
    Konstas AG, Papapanos P, Tersis I, Houliara D, Stewart WC.
    Ophthalmology; 2003 Jul; 110(7):1357-60. PubMed ID: 12867391
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Circadian IOP-lowering efficacy of travoprost 0.004% ophthalmic solution compared to latanoprost 0.005%.
    García-Feijoo J, Martínez-de-la-Casa JM, Castillo A, Méndez C, Fernández-Vidal A, García-Sánchez J.
    Curr Med Res Opin; 2006 Sep; 22(9):1689-97. PubMed ID: 16968572
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of latanoprost versus pilocarpine/timolol maleate fixed combination in patients with primary open-angle glaucoma or ocular hypertension.
    Kałuzny J, Sobecki R, Czechowicz-Janicka K, Kecik D, Kałuzny BJ, Stewart JA, Stewart WC.
    Acta Ophthalmol; 2008 Dec; 86(8):860-5. PubMed ID: 18721251
    [Abstract] [Full Text] [Related]

  • 16. Additive effect of dorzolamide or carteolol to latanoprost in primary open-angle glaucoma: a prospective randomized crossover trial.
    Maruyama K, Shirato S.
    J Glaucoma; 2006 Aug; 15(4):341-5. PubMed ID: 16865013
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Feasibility and efficacy of a mass switch from latanoprost to bimatoprost in glaucoma patients in a prepaid Health Maintenance Organization.
    Law SK, Song BJ, Fang E, Caprioli J.
    Ophthalmology; 2005 Dec; 112(12):2123-30. PubMed ID: 16225924
    [Abstract] [Full Text] [Related]

  • 20. Switching from latanoprost to fixed-combination latanoprost-timolol: a 21-day, randomized, double-masked, active-control study in patients with glaucoma and ocular hypertension.
    Olander K, Zimmerman TJ, Downes N, Schoenfelder J, Xalacom/Latanoprost Study Group.
    Clin Ther; 2004 Oct; 26(10):1619-29. PubMed ID: 15598478
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.